Talicia is a Oral Capsule, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Redhill Biopharma Ltd. The primary component is Omeprazole Magnesium; Amoxicillin; Rifabutin.
| Product ID | 57841-1150_0f01718c-c8cb-4894-8463-6b738a34b248 |
| NDC | 57841-1150 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Talicia |
| Generic Name | Omeprazole Magnesium, Amoxicillin And Rifabutin |
| Dosage Form | Capsule, Delayed Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-03-09 |
| Marketing Category | NDA / NDA |
| Application Number | NDA213004 |
| Labeler Name | RedHill Biopharma Ltd |
| Substance Name | OMEPRAZOLE MAGNESIUM; AMOXICILLIN; RIFABUTIN |
| Active Ingredient Strength | 10 mg/1; mg/1; mg/1 |
| Pharm Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Penicillin-class Antibacterial [EPC],Penicillins [CS],Rifamycin Antimycobacterial [EPC],Rifamycins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2020-03-09 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA213004 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2020-03-09 |
| Marketing Category | NDA |
| Application Number | NDA213004 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2020-03-09 |
| Ingredient | Strength |
|---|---|
| OMEPRAZOLE MAGNESIUM | 10 mg/1 |
| SPL SET ID: | 68c4e9dc-dbcf-4151-b6f7-5e4b9922b76f |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() TALICIA 88675178 not registered Live/Pending |
RedHill Biopharma, Ltd. 2019-10-31 |
![]() TALICIA 88391531 not registered Live/Pending |
RedHill Biopharma, Ltd. 2019-04-18 |
![]() TALICIA 87235778 5392689 Live/Registered |
RedHill Biopharma, Ltd. 2016-11-14 |